Consistent with these findings, DOT1L inhibition by EPZ004777 was found to be effective in increasing E-cadherin levels in BC cells, by repressing some key transcription factors involved in EMT promotion in these cells (Cho et al., 2015). This evidence concerns the gene DOT1L and breast cancer.